These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26139297)
1. Coronary Stent Materials and Coatings: A Technology and Performance Update. O'Brien B; Zafar H; Ibrahim A; Zafar J; Sharif F Ann Biomed Eng; 2016 Feb; 44(2):523-35. PubMed ID: 26139297 [TBL] [Abstract][Full Text] [Related]
2. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model. Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590 [TBL] [Abstract][Full Text] [Related]
3. Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach. Hassan S; Ali MN; Ghafoor B J Cardiothorac Surg; 2022 Apr; 17(1):65. PubMed ID: 35379273 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507 [TBL] [Abstract][Full Text] [Related]
5. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries. Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946 [TBL] [Abstract][Full Text] [Related]
6. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent. Waksman R; Pakala R EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674 [TBL] [Abstract][Full Text] [Related]
7. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Smits PC; Hofma S; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; Vuillomenet A; Serra A; Nouche RT; den Heijer P; van der Ent M Lancet; 2013 Feb; 381(9867):651-60. PubMed ID: 23374650 [TBL] [Abstract][Full Text] [Related]
8. Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. Kufner S; Byrne RA; Valeskini M; Schulz S; Ibrahim T; Hoppmann P; Schneider S; Laugwitz KL; Schunkert H; Kastrati A; EuroIntervention; 2016 Mar; 11(12):1372-9. PubMed ID: 25405657 [TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents - what should be improved? Steffel J; Eberli FR; Lüscher TF; Tanner FC Ann Med; 2008; 40(4):242-52. PubMed ID: 18428018 [TBL] [Abstract][Full Text] [Related]
10. New generation coronary stent technology--is the future biodegradable? Sammel AM; Chen D; Jepson N Heart Lung Circ; 2013 Jul; 22(7):495-506. PubMed ID: 23548335 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Kaiser C; Galatius S; Jeger R; Gilgen N; Skov Jensen J; Naber C; Alber H; Wanitschek M; Eberli F; Kurz DJ; Pedrazzini G; Moccetti T; Rickli H; Weilenmann D; Vuillomenet A; Steiner M; Von Felten S; Vogt DR; Wadt Hansen K; Rickenbacher P; Conen D; Müller C; Buser P; Hoffmann A; Pfisterer M; Circulation; 2015 Jan; 131(1):74-81. PubMed ID: 25411159 [TBL] [Abstract][Full Text] [Related]
12. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents. Chen W; Habraken TC; Hennink WE; Kok RJ Bioconjug Chem; 2015 Jul; 26(7):1277-88. PubMed ID: 26041505 [TBL] [Abstract][Full Text] [Related]
13. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform. Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088 [TBL] [Abstract][Full Text] [Related]
15. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
16. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
17. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating. Jabara R; Chronos N; Robinson K Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646 [TBL] [Abstract][Full Text] [Related]
18. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117 [TBL] [Abstract][Full Text] [Related]
19. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419 [TBL] [Abstract][Full Text] [Related]